Evidence map›Paper›PMID 29221118›Full record

ArticleOncotarget2017

Lentinan dose dependence between immunoprophylaxis and promotion of the murine liver cancer.

Ying Wang, Xue Han, Yan Dong Li, Yabing Wang, Shi Yang Zhao, Dong Jie Zhang, Yu Lu

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 16 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ying WangCollege of Food, Heilongjiang Bayi Agricultural University, Daqing 163319, PR China.
Xue HanCollege of Biological Science and Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, PR China.
Yan Dong LiHebei Institute of Veterinary Drugs Control, Shijiazhuang 050000, PR China.
Yabing WangCollege of Biological Science and Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, PR China.
Shi Yang ZhaoCollege of Biological Science and Engineering, Hebei University of Science and Technology, Shijiazhuang 050018, PR China.
Dong Jie ZhangCollege of Food, Heilongjiang Bayi Agricultural University, Daqing 163319, PR China.
Yu LuHuabei Petroleum Administration Bureau, Huasheng Integrated Service, Tianjin 300000, PR China.
Heilongjiang Bayi Agricultural University · CNHebei University of Science and Technology · CNChina Institute of Veterinary Drug Control · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lentinan could exhibit significant biological activity favorable for human health and disease control such as the recovery of patients with liver cancer. In order to investigate the effect of lentinan dose dependence between immunoprophylaxis and promotion of cancer cell proliferation of the murine liver cancer, different concentrations of lentinan were prepared for the test

Indexed as

dose dependenceimmunoprophylaxislentinanliver cancerpromotion

Identifiers

PMID29221118
PMCPMC5707012
OpenAlexW2741556658

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.